Form 4: Core Scientific Exec Sells Shares Under 10b5-1 Plan

Core Scientific, Inc. reports that Chief Legal and Administrative Officer Todd DuChene sold 10,000 shares of common stock for $22.625 per share as part of a pre-arranged trading plan.

Summary

• Todd DuChene, Chief Legal and Administrative Officer of Core Scientific, Inc., sold 10,000 shares of common stock.
• The transaction occurred on July 6, 2026, with a weighted average sale price of $22.625 per share.
• These shares were sold in multiple transactions at prices ranging from $22.24 to $23.15.
• The sale was executed under a Rule 10b5-1 trading plan adopted by DuChene on December 5, 2025.
• Following the transaction, DuChene beneficially owns 2,023,426 shares of common stock.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, as the sale was conducted under a pre-established Rule 10b5-1 plan, indicating it was planned in advance and not based on current non-public information.

Future Outlook

The filing does not contain forward-looking statements or guidance.

Industry Context

StockSavvy.ai notes that insider sales under Rule 10b5-1 plans are common for executives to diversify holdings or manage personal finances, and are generally not viewed negatively by the market if executed as planned.

Stakeholder Impact

• Shareholders: The sale is executed under a pre-arranged plan, suggesting it is not indicative of negative sentiment towards the company's future prospects, but rather a planned personal financial transaction by an executive.

Key Dates

Keywords

Core Scientific, CORZ, Form 4, insider trading, Rule 10b5-1, stock sale, beneficial ownership